REGENXBIO Inc. (RGNX): Price and Financial Metrics

REGENXBIO Inc. (RGNX): $9.63

0.07 (+0.73%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add RGNX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#135 of 332

in industry

RGNX Price/Volume Stats

Current price $9.63 52-week high $28.80
Prev. close $9.56 52-week low $8.53
Day low $9.01 Volume 806,100
Day high $9.80 Avg. volume 623,576
50-day MA $10.37 Dividend yield N/A
200-day MA $14.28 Market Cap 477.12M

RGNX Stock Price Chart Interactive Chart >


REGENXBIO Inc. (RGNX) Company Bio


REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy. The company was founded in 2009 and is based in Rockville, Maryland.


RGNX Latest News Stream


Event/Time News Detail
Loading, please wait...

RGNX Latest Social Stream


Loading social stream, please wait...

View Full RGNX Social Stream

RGNX Price Returns

1-mo 0.42%
3-mo -20.61%
6-mo -35.46%
1-year -49.66%
3-year -71.44%
5-year -74.89%
YTD -46.35%
2023 -20.86%
2022 -30.64%
2021 -27.91%
2020 10.72%
2019 -2.34%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!